Product Liability Lawyer Blog
The number of men taking hormone replacement therapy has gone up by over 400 percent in the past 10 years. The main reason for this is not because more men have developed the relatively rare medical condition known as hypogonadism (the only FDA approved reason for testosterone hormone), but because the drug companies have spent a lot of money marketing the hormone regimen for men who are experiencing the normal signs of male aging.
These signs of normal male aging include loss of libido, weight gain, tiredness, muscle fatigue and mild depression, among others. The makers of testosterone replacement therapy drugs and the owners and operators so called “T clinics” are using testosterone for the off-label use of allegedly treating these “symptoms” of the normal male aging process.
However, there is not much support in the medical community over whether testosterone therapy can actually offer any positive benefit for men who do not suffer from hypogonadism. There is, however, a growing consensus among doctors and scientists that taking testosterone therapy can increase the risk of stroke and heart attack in men, as our Boston testosterone replacement injury attorneys can explain.
According to a recent news article from Medical Daily, a new study shows that testosterone replacement therapy does not solve ejaculation problems, even when those problems are believed to be caused by a low testosterone level or “low T count.” It has been suggested that having a lower than average testosterone level may be a major contributor to men who had problems with ejaculation.
The new study suggests the relationship between having a lower testosterone level and problems with ejaculation may exist, but it may be a more indirect than people initially believed. The study also suggests that men who are given testosterone replacement therapy hormone will not see any improvement in sexual function. This news will come as a major disappointment to many of the men who are taking testosterone replacement hormone, because is one of the major reasons people take the drug. However, most of the claims that testosterone replacement hormone actually benefit men with any condition are not based on actual science.
Many of the critics of testosterone replacement hormone being marketed to men who are “suffering” from the normal characteristics of aging believe the drug companies are engaging in what is commonly referred to as “disease mongering.” This is the process where drug companies look for new markets for existing products that are not selling well. They pay advertising firms to come up with new markets and create names for rare illnesses and then develop commercials to suggest to patients they have these medical conditions and will benefit from a new medication. They typically try to come up with names people are comfortable with, so they will be more likely to ask their doctors for a new drug. For example, impotence became erectile dysfunction. Erectile dysfunction became “ED,” so men are more comfortable telling their doctors they have ED than telling them they are impotent.
If you are the victim of Massachusetts product liability due to taking testosterone hormone, call Jeffrey Glassman Injury Lawyers for a free and confidential appointment — (617) 777-7777.
Additional Resources:
Testosterone Replacement Therapy Doesn’t Solve Ejaculation Problems Linked To Low T: Study, July 9, 2015, Medical Daily
More Blog Entries:
Risk for Internal Bleeding after Taking Pradaxa, August 22, 2014, Boston Dangerous Drugs Injury Lawyer Blog